Erbitux and Vectibix both work in similar ways to fight The Cancer. However, a recent study (from June 6th!) shows that Erbitux, and thus, probably Vectibix, is only potent against tumors with a very specific trait. Of course, Maggie and I insisted that her tumor be tested for this trait because, damn it, if we are going to deal with all these unpleasantries we want to know that at least we’ve got a fighting chance. Today, Nurse Mary from The Spa called to let us know that the genetic testing was complete and our tumors do, in fact, have that specific trait. Good news!
To be more specific, the trait is actually the absence of a mutated KRAS gene, also called “wild type” no doubt for its rude behavior in socially-sensitive situations. Presence of the mutated KRAS gene would mean that we are unlikely to benefit from the Vectibix. Fortunately, all our KRAS are belong to us. No mutations! Happy, happy! Joy, joy!
P. S. If you didn’t laugh at least one time while reading this go back and try again. Despite being true, it’s very funny. Can’t make this stuff up.